Use of Second Generation Tyrosine Kinase Inhibitors for Second-Line Treatment of Chronic Myeloid Leukemia After Imatinib Failure
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi - Turkey
doi 10.4999/uhod.11012
Full Text
Open PDFAbstract
Available in full text
Date
June 30, 2011
Authors
Publisher
Akademi Doktorlar Yayinevi